The Diabetes Diagnostics Market was valued at USD 33.44 Bn. in 2024, and the total Diabetes Diagnostics Market revenue is expected to grow at a CAGR of 7.8% from 2025 to 2032, reaching nearly USD 60.98 Bn. by 2032.Global Diabetes Diagnostics Market Overview
Diabetes diagnostics is a device and solution designed to monitor and manage blood glucose levels, including blood glucose monitors (BGM), continuous glucose monitoring (CGM) systems, and insulin delivery devices. The diabetes diagnostics market is growing due to rising diabetes prevalence, technological advancements, and increasing adoption of digital health solutions, with AI and telemedicine enhancing real-time data tracking. Demand has been increasing due to growing awareness and government healthcare initiatives, while supply chain challenges in regions like Asia and Africa create gaps in accessibility. North America dominated the Diabetes Diagnostics Market, due to high healthcare spending and favourable reimbursement policies, while Asia Pacific emerges as fastest fastest-growing region by its lifestyle changes and increasing awareness. Key players like Roche Diagnostics, Abbott Laboratories, and Medtronic lead through innovation, strategic partnership, and advanced CGM technology. The hospital segment holds the largest market share due to advanced infrastructure, while home care is rising with portable diagnostics. Trade policies and regulatory approvals significantly impact market dynamics, with cost-effective solutions gaining traction in emerging economies. The report covered the Diabetes Diagnostics Market dynamics, structure by analyzing the market segments and projecting the Diabetes Diagnostics Market size. Competitive analysis of key players by type, price, financial position, product portfolio, growth strategies and regional presence in the Diabetes Diagnostics Market.To know about the Research Methodology :- Request Free Sample Report
Global Diabetes Diagnostics Market Dynamics
Growing Preventive Awareness and Technological Integration to Drive Diabetes Diagnostics Market Growth Increased awareness of preventive considerations and innovative factors is helpful for the driving diabetes diagnostics market. Patients are utilizing computer-based applications that can connect with these smart blood glucose monitoring devices. To manage patients' requirements, there are numerous administrative drives and learning stages. For Example, with one year of limitless admittance to ensure diabetes mentors. Patients are also using a glucose monitoring device for their diagnosis. Governments are increasing funding in the healthcare sector and private hospitals. Supply-Demand Gaps in Emerging Regions to Pose Challenges for the Diabetes Diagnostics Market Diabetes diagnostics play an important role in performing the test and diagnosis of the disease. Countries like Asia and Africa have a gap between the supply and demand of manufacturers may challenges for the market.Global Diabetes Diagnostics Market Segment Analysis
Based on the product, the global diabetes diagnostic market is sub-segmented into BGM Devices, Continuous Glucose Monitoring Devices, and Insulin Delivery Devices. The insulin delivery device has held a large share, having xx% in 2024. Factors contributing to the segment's growth are rising adoption of insulin pumps, improved patient satisfaction and adherence, and technological advancement. Additionally, this device is user-friendly, and the comfort of injection makes insulin easier. The ease of use of this device and the flexibility of incorporating insulin injections into a busy lifestyle may improve diabetes control with fewer efforts. Due to all these reasons, the demand for insulin delivery devices has increased. The BGM (blood glucose monitoring) held the second-largest share of xx% in 2024. Rising awareness about diabetes devices and technological advancement, high usage, and low cost, results in a quick response with accurate diagnostics. The newest devices display blood glucose readings on a screen, so you can see the result in real-time, whether blood glucose levels are rising or falling. Based on an end-user, the global diabetes diagnostic market is sub-segmented into Hospitals, Homecare, and Diagnostic Centers. According to the MMR report, the hospital segment held the largest market share, having 45% in the year 2024. The hospital segment is expected to grow fast rate of xx% during the forecast period. Due to the increasing number of private hospitals and the number of patients, due to trained staff, good equipment, and good facilities, many people choose hospitals for their operation due as all these factors demand of the hospital segment are increasing rapidly.Global Diabetes Diagnostics Market Regional Insights
North America has the biggest diabetes diagnostics market in the world; it held xx% of the share in the year 2024, owing to the increasing number of patients and a favorable reimbursement scenario. According to the WHO, 48 million people in North America were suffering from diabetes in 2024, and the number is expected to reach 63 million by 2045. In December 2021, Companion Medical Launched Inpen, its first smart insulin pen system in the U.S., which is an FDA-supported system that can consolidate an insulin injector pen with a smart application. In 2024, APAC held the second-largest market share, xx% of the global market, owing to rising good strategies, increased convenience, a shift towards high-calorie energy-rich foods, changing lifestyles, and rising awareness about diabetes devices. Government drives and educational projects are likewise moving the market during the forecasting period. Global Diabetes Diagnostics Market Competitive Landscape Key players like Roche Diagnostics, Abbott Laboratories, Johnson & Johnson, Siemens Healthineers (Germany) and Medtronic plc (Ireland) dominate the Diabetes diagnostics market. Companies are led by strong R&D investments, continuous product innovation, and extensive global distribution network. Roche Diagnostics excels with its advanced glucose monitoring systems and integrated digital health solutions, while Abbott Laboratories focuses on user-friendly, minimally invasive devices like FreeStyle Libre. Johnson & Johnson's strong brand presence and variety of healthcare portfolio, and Siemens Healthineers, focus on automation and AI-driven diagnostics. Medtronic, with its closed-loop insulin delivery system and continuous glucose monitoring technology. Their dominance is reinforced by strategic acquisition, partnership and regulatory approval, ensuring cutting-edge, reliable solutions for diabetes management. Also, focus on emerging markets and personalised healthcare further solidifies their leadership positions in this rapidly growing industry. companies invest heavily in telemedicine and AI-powered analytics to enhance diabetes management, offering real-time data tracking and predictive insight. Their commitment to cost effective, portable and high accuracy devices ensures accessibility for a broader patient base, further strengthening their market position. Global Diabetes Diagnostics Market Key Trends 1. Rising Adoption of Continuous Glucose Monitoring (CGM) Systems CGM devices are revolutionizing diabetes management with real-time glucose tracking, reducing reliance on traditional fingerstick tests. Demand is surging due to improved accuracy, AI-driven insights, and integration with insulin pumps. 2. Growth of Non-Invasive & Wearable Technologies Innovations like glucose-sensing smartwatches, patches, and optical sensors are gaining traction, offering pain-free monitoring and better patient compliance. Companies like Abbott (FreeStyle Libre) and Dexcom lead this space. 3. Expansion of Point-of-Care (POC) Testing Rapid HbA1c and blood glucose tests in clinics, pharmacies, and home settings are increasing, driven by the need for quick diagnostics and decentralised healthcare. Global Diabetes Diagnostics Market Recent Development • Abbott Laboratories (United States) May 15, 2025 – Abbott released a study showing that use of its FreeStyle Libre CGM reduced heart-related hospitalisations by 78% in type 1 diabetes and significantly reduced admissions in type 2 diabetes patients. April 29, 2025 – Abbott integrated FreeStyle Libre CGM data with Epic’s EHR system, enabling real-time glucose monitoring access for healthcare professionals. • Roche Diagnostics (Switzerland) May 12, 2025 – Roche announced a $550 million investment to build a continuous glucose monitoring (CGM) manufacturing facility in Indianapolis, aimed at expanding diabetes diagnostics capacity by 2030. May 6, 2025 – Roche launched the Elecsys® PRO‑C3 fibrosis test for use in diabetes patients with comorbid liver conditions, expanding diagnostic capability.Diabetes Diagnostics Market Scope: Inquire before buying
Diabetes Diagnostics Market Report Coverage Details Base Year: 2024 Forecast Period: 2025-2032 Historical Data: 2019 to 2024 Market Size in 2024: USD 33.44 Bn. Forecast Period 2025 to 2032 CAGR: 7.8% Market Size in 2032: USD 60.98 Bn. Segments Covered: by Product BGM Devices Continuous Glucose Monitoring Devices Insulin Delivery by End-User Hospitals Homecare Diagnostic Centers Global Diabetes Diagnostics Market, by region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Russia, Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Philippines, Malaysia, Vietnam, Thailand, Rest of Asia Pacific) Middle East and Africa (South Africa, Saudi Arabia, UAE, Rest of the Middle East &Africa) South America (Brazil, Argentina, Rest of South America)Global Diabetes Diagnostics Market Key Players
North America 1. Abbott Laboratories (United States) 2. Becton, Dickinson and Company (United States) 3. Bio-Rad Laboratories, Inc. (United States) 4. Danaher Corporation (United States) 5. Johnson & Johnson (United States) 6. Eli Lilly and Company (United States) 7. Nipro Diagnostics (United States) 8. Dexcom, Inc. (United States) Europe 9. Roche Diagnostics (Switzerland) 10. Siemens Healthineers (Germany) 11. Ascensia Diabetes Care (Switzerland) 12. Novo Nordisk A/S (Denmark) 13. Medtronic plc (Ireland) 14. EKF Diagnostics (United Kingdom) 15. Menarini Diagnostics (Italy) Asia Pacific 16. Terumo Corporation (Japan) 17. ACON Laboratories, Inc. (China) 18. Sinocare Inc. (China) 19. Arkray Inc. (Japan) 20. Panasonic Healthcare (Japan) Middle East & Africa 21. Trivitron Healthcare (India) 22. LifeScan Middle East (United Arab Emirates) South America 23. MedLevensohn (Brazil) 24. Bioclin (Brazil) 25. HTG Molecular Diagnostics Latin America (Brazil)Frequently Asked Questions:
1] What is the growth rate of the Global Diabetes Diagnostics Market? Ans. The diabetes diagnostics Market is growing at a CAGR of 7.8% during the forecasting period 2025-2032. 2] Which region is expected to dominate the Global Diabetes Diagnostics Market? Ans. North America is expected to dominate the Diabetes Diagnostics Market during the forecast period. 3] What is the expected Global Diabetes Diagnostics Market size by 2032? Ans. The Diabetes Diagnostics Market size is expected to reach USD 60.98 Bn by 2032. 4] Which are the top players in the Global Diabetes Diagnostics Market? Ans. The major top players in the Global Diabetes Diagnostics Market are Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Becton, Dickinson and Company, Dexcom, Medtronic, Johnson & Johnson, and Novo Nordisk. 5] What segments are covered in the diabetes diagnostics Market? Ans. Global diabetes diagnostics Market is segmented based on Product, End-user and Region.
1. Diabetes Diagnostics Market Introduction 1.1. Study Assumptions and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Diabetes Diagnostics Market: Competitive Landscape 2.1. Ecosystem Analysis 2.2. MMR Competition Matrix 2.3. Competitive Landscape 2.4. Key Players Benchmarking 2.4.1. Company Name 2.4.2. Service Segment 2.4.3. End-User Segment 2.4.4. Revenue (2024) 2.4.5. Geographical Presence 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 2.7. KANO Model Analysis 3. Diabetes Diagnostics Market: Dynamics 3.1. Region-wise Trends of Diabetes Diagnostics Market 3.1.1. North America Diabetes Diagnostics Market Trends 3.1.2. Europe Diabetes Diagnostics Market Trends 3.1.3. Asia Pacific Diabetes Diagnostics Market Trends 3.1.4. Middle East and Africa Diabetes Diagnostics Market Trends 3.1.5. South America Diabetes Diagnostics Market Trends 3.2. Diabetes Diagnostics Market Dynamics 3.2.1. Diabetes Diagnostics Market Drivers 3.2.1.1. Increased Preventive Awareness 3.2.1.2. Tech-Enabled Monitoring Tools 3.2.2. Diabetes Diagnostics Market Restraints 3.2.3. Diabetes Diagnostics Market Opportunities 3.2.3.1. Digital Health Integration 3.2.3.2. Growing Homecare Demand 3.2.3.3. Emerging Market Penetration 3.2.4. Diabetes Diagnostics Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.4.1. Public-private healthcare funding 3.4.2. Rising healthcare expenditure 3.4.3. Smart glucose monitoring devices 3.5. Regulatory Landscape by Region 3.6. Key Opinion Leader Analysis for the Global Industry 3.7. Analysis of Government Schemes and Initiatives for Industry 4. Diabetes Diagnostics Market: Global Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032) 4.1. Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 4.1.1. BGM Devices 4.1.2. Continuous Glucose Monitoring Devices 4.1.3. Insulin Delivery 4.2. Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 4.2.1. Hospitals 4.2.2. Homecare 4.2.3. Diagnostic Centers 4.3. Diabetes Diagnostics Market Size and Forecast, By Region (2024-2032) 4.3.1. North America 4.3.2. Europe 4.3.3. Asia Pacific 4.3.4. Middle East and Africa 4.3.5. South America 5. North America Diabetes Diagnostics Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032) 5.1. North America Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 5.1.1. BGM Devices 5.1.2. Continuous Glucose Monitoring Devices 5.1.3. Insulin Delivery 5.2. North America Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 5.2.1. Hospitals 5.2.2. Homecare 5.2.3. Diagnostic Centers 5.3. North America Diabetes Diagnostics Market Size and Forecast, by Country (2024-2032) 5.3.1. United States 5.3.1.1. United States Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 5.3.1.1.1. BGM Devices 5.3.1.1.2. Continuous Glucose Monitoring Devices 5.3.1.1.3. Insulin Delivery 5.3.1.2. United States Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 5.3.1.2.1. Hospitals 5.3.1.2.2. Homecare 5.3.1.2.3. Diagnostic Centers 5.3.2. Canada 5.3.2.1. Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 5.3.2.1.1. BGM Devices 5.3.2.1.2. Continuous Glucose Monitoring Devices 5.3.2.1.3. Insulin Delivery 5.3.2.2. Canada Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 5.3.2.2.1. Hospitals 5.3.2.2.2. Homecare 5.3.2.2.3. Diagnostic Centers 5.3.3. Mexico 5.3.3.1. Mexico Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 5.3.3.1.1. BGM Devices 5.3.3.1.2. Continuous Glucose Monitoring Devices 5.3.3.1.3. Insulin Delivery 5.3.3.2. Mexico Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 5.3.3.2.1. Hospitals 5.3.3.2.2. Homecare 5.3.3.2.3. Diagnostic Centers 6. Europe Diabetes Diagnostics Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032) 6.1. Europe Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 6.2. Europe Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 6.3. Europe Diabetes Diagnostics Market Size and Forecast, by Country (2024-2032) 6.3.1. United Kingdom 6.3.1.1. United Kingdom Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 6.3.1.2. United Kingdom Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 6.3.2. France 6.3.2.1. France Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 6.3.2.2. France Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 6.3.3. Germany 6.3.3.1. Germany Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 6.3.3.2. Germany Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 6.3.4. Italy 6.3.4.1. Italy Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 6.3.4.2. Italy Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 6.3.5. Spain 6.3.5.1. Spain Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 6.3.5.2. Spain Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 6.3.6. Sweden 6.3.6.1. Sweden Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 6.3.6.2. Sweden Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 6.3.7. Russia 6.3.7.1. Russia Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 6.3.7.2. Russia Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 6.3.8. Rest of Europe 6.3.8.1. Rest of Europe Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 6.3.8.2. Rest of Europe Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 7. Asia Pacific Diabetes Diagnostics Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032) 7.1. Asia Pacific Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 7.2. Asia Pacific Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 7.3. Asia Pacific Diabetes Diagnostics Market Size and Forecast, by Country (2024-2032) 7.3.1. China 7.3.1.1. China Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 7.3.1.2. China Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 7.3.2. S Korea 7.3.2.1. S Korea Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 7.3.2.2. S Korea Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 7.3.3. Japan 7.3.3.1. Japan Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 7.3.3.2. Japan Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 7.3.4. India 7.3.4.1. India Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 7.3.4.2. India Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 7.3.5. Australia 7.3.5.1. Australia Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 7.3.5.2. Australia Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 7.3.6. Indonesia 7.3.6.1. Indonesia Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 7.3.6.2. Indonesia Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 7.3.7. Malaysia 7.3.7.1. Malaysia Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 7.3.7.2. Malaysia Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 7.3.8. Philippines 7.3.8.1. Philippines Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 7.3.8.2. Philippines Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 7.3.9. Thailand 7.3.9.1. Thailand Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 7.3.9.2. Thailand Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 7.3.10. Vietnam 7.3.10.1. Vietnam Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 7.3.10.2. Vietnam Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 7.3.11. Rest of Asia Pacific 7.3.11.1. Rest of Asia Pacific Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 7.3.11.2. Rest of Asia Pacific Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 8. Middle East and Africa Diabetes Diagnostics Market Size and Forecast (by Value in USD Billion) (2024-2032 8.1. Middle East and Africa Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 8.2. Middle East and Africa Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 8.3. Middle East and Africa Diabetes Diagnostics Market Size and Forecast, by Country (2024-2032) 8.3.1. South Africa 8.3.1.1. South Africa Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 8.3.1.2. South Africa Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 8.3.2. GCC 8.3.2.1. GCC Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 8.3.2.2. GCC Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 8.3.3. Egypt 8.3.3.1. Egypt Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 8.3.3.2. Egypt Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 8.3.4. Nigeria 8.3.4.1. Nigeria Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 8.3.4.2. Nigeria Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 8.3.5. Rest of ME&A 8.3.5.1. Rest of ME&A Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 8.3.5.2. Rest of ME&A Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 9. South America Diabetes Diagnostics Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2032 9.1. South America Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 9.2. South America Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 9.3. South America Diabetes Diagnostics Market Size and Forecast, by Country (2024-2032) 9.3.1. Brazil 9.3.1.1. Brazil Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 9.3.1.2. Brazil Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 9.3.2. Argentina 9.3.2.1. Argentina Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 9.3.2.2. Argentina Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 9.3.3. Colombia 9.3.3.1. Colombia Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 9.3.3.2. Colombia Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 9.3.4. Chile 9.3.4.1. Chile Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 9.3.4.2. Chile Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 9.3.5. Rest Of South America 9.3.5.1. Rest Of South America Diabetes Diagnostics Market Size and Forecast, By Product (2024-2032) 9.3.5.2. Rest Of South America Diabetes Diagnostics Market Size and Forecast, By End-User (2024-2032) 10. Company Profile: Key Players 10.1. Abbott Laboratories (United States) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Developments 10.2. Becton, Dickinson and Company (United States) 10.3. Bio-Rad Laboratories, Inc. (United States) 10.4. Danaher Corporation (United States) 10.5. Johnson & Johnson (United States) 10.6. Eli Lilly and Company (United States) 10.7. Nipro Diagnostics (United States) 10.8. Dexcom, Inc. (United States) 10.9. Roche Diagnostics (Switzerland) 10.10. Siemens Healthineers (Germany) 10.11. Ascensia Diabetes Care (Switzerland) 10.12. Novo Nordisk A/S (Denmark) 10.13. Medtronic plc (Ireland) 10.14. EKF Diagnostics (United Kingdom) 10.15. Menarini Diagnostics (Italy) 10.16. Terumo Corporation (Japan) 10.17. ACON Laboratories, Inc. (China) 10.18. Sinocare Inc. (China) 10.19. Arkray Inc. (Japan) 10.20. Panasonic Healthcare (Japan) 10.21. Trivitron Healthcare (India) 10.22. LifeScan Middle East (United Arab Emirates) 10.23. MedLevensohn (Brazil) 10.24. Bioclin (Brazil) 10.25. HTG Molecular Diagnostics Latin America (Brazil) 11. Key Findings 12. Industry Recommendations 13. Diabetes Diagnostics Market: Research Methodology
